Last edition
News about "Eli Lilly to Divest New Jersey Plant Amidst USD 27"
Eli Lilly to Divest New Jersey Plant Amidst USD 27 Billion U.S. Manufacturing Expansion
As Eli Lilly advances its ambitious USD 27 billion investment plan to establish four new manufacturing facilities in the United States, the company has confirmed plans to sell its existing production site in Branchburg, New Jersey—a facility that has faced regulatory scrutiny in the past.
Eli Lilly To Divest New Jersey Plant Amidst USD 27 | 07/08/2025 | By Darshana | 599
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members